=20 Nanotech and biotech Convergence-2003 The Second Annual BCC Conference May 4-6, 2003; Holiday Inn Select, Stamford, CT, USA www.bccresearch.com/nanobio2003 exhibiting and sponsership opportunites available (For Schedule of Invited Speakers, see below) Bioassays which incorporate nanotechnology dramatically increase sensitivit= y,=20 while reducing assay volumes and reagent use. In the long run, they will= =20 also be much cheaper and more automated. At risk are conventional=20 microarray, ELISA, PCR based assays. Nanotechnology is also showing up in= =20 drug delivery systems and medical imaging modalities. Call for Posters=20=20 Please Send Abstracts to: Steven A. Edwards Program Chairman=20 Nano2bio@aol.com Pre-Conference Workshop Trends in Nanoscale Diagnostic Technologies Michael Pishko, Penn State, and Juan Yguerabide, Genicon Sciences Nanotech and Biotech Convergence-2003 Revised Schedule Enabling Technologies Bio-nanotechnology at IBM Research Glenn A. Held IBM T.J. Watson Research Center Yorktown Heights, New York Glen A. Evans, TBA (Rapid DNA Synthesis) Chief Executive Officer=20 Egea Biosciences, Inc.=20 San Diego, California High throughput operations at the nanoscale through the use of miniature=20 instrumented robots Sylvain Martel=20=20 Director, NanoRobotics Laboratory, =C9cole Polytechnique de Montr=E9al (EPM= ),=20 Campus of University of Montr=E9al, Montr=E9al, Canada, and researcher at= =20 Bioinstrumentation Lab, MIT, Cambridge, MA Virgil Percec TBA (polymers) Professor, Dept. of Chemistry University of Pennsylvania Philadelphia, PA Biosensing Applications of Nanoshells Naomi Halas Professor of Electrical and Computer Engineering and Professor of Chemistry,=20 Rice University, Houston, TX NanoParticle Based Bioassays Bioconjugated nanoparticles for bioanalysis and biotechnology applications Weihong Tan Professor Department of Chemistry University of Florida Gainesville, FL Bioassays with Striped Metallic Nanoparticles=20 Michael J. Natan, Chief Executive Officer Nanoplex Technologies, Inc.,=20 Mountain View, CA Resonance Light Scattering Nanoparticles as Labels for Ultrasensitive Analy= te=20 Detection Juan Yguerabide=20=20=20 Professor Emeritus, UCSD Vice President of Discovery Genicon Sciences Acoustic sensing of molecular interactions Matthew Cooper Chief Scientific Officer, Akubio Ltd. Cambridge, England, UK Cantilevers and Nanotubes Dip Pen Nanolithography Guy della Cioppa,=20 Executive Vice President NanoInk, Inc. Chicago, IL Biological NanoArrays Eric Henderson=20=20=20 Founder and Chief Science Officer BioForce Nanosciences Ames, Iowa Otto Zhou TBA (nanotube X-ray device) Associate Professor of Physics and Applied Materials Sciences University of North Carolina Chairman, Applied Nanotechnologies Chapel Hill, North Carolina Sebastian A. Kossek TBA (cantilever assays) Vice President, Research Protiveris Rockville, Maryland Electrochemistry and Microfluidics Cell-based bioassays in microfluidic systems Michael Pishko Professor Dept. of Chemical Engineering, Penn State University Park, Pennsylvania Applications of Microtransponders in High Speed, Multiplexed Biological=20 Assays Wlodek Mandecki=20 Pharmaseq, Inc. Monmouth Junction, New Jersey Nanoliter and Picoliter Liquid Handling for Life Science Applications Richard Ellson Chief Technology Officer, Picoliter, Inc. Sunnyvale, CA Controlled Wetting in Microfluidics: =46rom Microarrays to Droplet-Based Digital LabChips Karsten Reihs=20 Marnaging Director, Science and Technology SuNyx Surface Technologies GmbH Cologne, Germany Detection of Biological Warfare Agents Kalle Levon Director, Polymer Research Institute Polytechnic University Brooklyn, New York Bionanotechnology in molecular analysis Vincent Gau President and CEO GeneFluidics Monterey Park, California Funding and Commercialization Issues DARPA Funding of Nanobiotechnology Projects Anantha Krishnan Program Manager, Defense Sciences Office Defense Advanced Research Projects Agency Arlington, Virginia=20=20 =20=20 Do More with Less: Creative Intellectual Property Strategies to Maximize=20 Profits and Revenues While Minimizing Expenditures on Your Portfolio David A. Kalow Managing Partner Kalow and Springut New York, New York Patents and Protecting Your Invention Rights Lisa M. Caldwell=20=20 Patent Attorney Klarquist Sparkman, LLP Portland, Oregon Biomedical Applications of Nanoscale Devices-Commercial Opportunities Steven Edwards Analyst BCC, Inc. Christiana, Tennessee To RegisterOnline:=20 > www.bus com.c= om/nanobio2003/registration.html Questions, contact: Sharon Faust: Conference Coordinator. > 203-853-4266; ext: 304; 203-853-0348, Email: conference@bccresearch.com [[alternate HTML version deleted]]